柴芍六君子汤加减治疗肝病的临床研究进展  

Clinical Research Progress on Modified Chaishao Liujunzi Decoction in the Treatment of Hepatic Diseases

作　　者：梅露 黄古叶[2] 许宏平 吴玉莹 陈华林 莫柏林 

机构地区：[1]广西中医药大学第一临床医学院,广西 南宁 [2]广西中医药大学第一附属医院,广西 南宁

出　　处：《中医学》2024年第4期680-685,共6页Traditional Chinese Medicine

摘　　要：柴芍六君子汤出自清代医家吴谦所著《医宗金鉴》,是中医的经典药方,具有疏肝健脾的功效,是治疗肝郁脾虚型疾病的基础方之一,广泛应用于临床。其在治疗肝脏疾病如慢乙肝、肝纤维化、肝硬化及肝癌等方面也疗效显著。现对柴芍六君子汤治疗肝病的临床研究进展进行综述,为中医药治疗肝病提供参考。Chaishao Liujunzi Decoction is a classic Chinese medicine prescription in “Golden Mirror of Medicine”, a book written by one Qing dynasty doctor, Wu Qian. It can relieve the stagnant qi in liver and strengthen the qi in spleen, also is one of the fundamental prescriptions to treat syndrome of liver depression and spleen deficiency. This prescription is widely used to treat hepatic diseases such as Chronic Hepatitis B (CHB), hepatic fibrosis, hepatic cirrhosis and primary carcinoma of the liver. This paper summarizes the clinical research progress of the Chaishao Liujunzi Decoction in the treatment of liver diseases, and also helps provide reference for the application of TCM in the treatment of hepatic diseases.

关 键 词：柴芍六君子汤 肝脏疾病 异病同治 临床研究 

分 类 号：R25[医药卫生—中医内科学]